| Product NDC: | 49884-099 |
| Proprietary Name: | Propafenone Hydrochloride |
| Non Proprietary Name: | propafenone hydrochloride |
| Active Ingredient(s): | 225 mg/1 & nbsp; propafenone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-099 |
| Labeler Name: | Par Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078540 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110103 |
| Package NDC: | 49884-099-10 |
| Package Description: | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-099-10) |
| NDC Code | 49884-099-10 |
| Proprietary Name | Propafenone Hydrochloride |
| Package Description | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-099-10) |
| Product NDC | 49884-099 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | propafenone hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110103 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | PROPAFENONE HYDROCHLORIDE |
| Strength Number | 225 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |